{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T22:53:49Z","timestamp":1726095229977},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T00:00:00Z","timestamp":1353283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T00:00:00Z","timestamp":1353283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/leu.2012.331","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T07:40:23Z","timestamp":1353310823000},"page":"1146-1154","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["CBL-B is required for leukemogenesis mediated by BCR-ABL through negative regulation of bone marrow homing"],"prefix":"10.1038","volume":"27","author":[{"given":"K M","family":"Badger-Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L C","family":"Gillis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M L","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J M","family":"Penninger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D L","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,19]]},"reference":[{"key":"BFleu2012331_CR1","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/nrc1567","volume":"5","author":"R Ren","year":"2005","unstructured":"Ren R . Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia. Nat Rev Cancer 2005; 5: 172\u2013183.","journal-title":"Nat Rev Cancer"},{"key":"BFleu2012331_CR2","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL . Chronic myeloid leukemia. N Engl J Med 1999; 340: 1330\u20131340.","journal-title":"N Engl J Med"},{"key":"BFleu2012331_CR3","doi-asserted-by":"publisher","first-page":"9312","DOI":"10.1073\/pnas.85.23.9312","volume":"85","author":"GQ Daley","year":"1988","unstructured":"Daley GQ, Baltimore D . Transformation of an interleukin 3-dependent hematopoietic cell line by the chronic myelogenous leukemia-specific P210bcr\/abl protein. Proc Natl Acad Sci USA 1988; 85: 9312\u20139316.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR4","first-page":"387","volume":"3","author":"IK Hariharan","year":"1988","unstructured":"Hariharan IK, Adams JM, Cory S . bcr-abl oncogene renders myeloid cell line factor independent: potential autocrine mechanism in chronic myeloid leukemia. Oncogene Res 1988; 3: 387\u2013399.","journal-title":"Oncogene Res"},{"key":"BFleu2012331_CR5","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","volume":"83","author":"A McGahon","year":"1994","unstructured":"McGahon A, Bissonnette R, Schmitt M, Cotter KM, Green DR, Cotter TG . BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death. Blood 1994; 83: 1179\u20131187.","journal-title":"Blood"},{"key":"BFleu2012331_CR6","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood.V83.8.2038.2038","volume":"83","author":"A Bedi","year":"1994","unstructured":"Bedi A, Zehnbauer B, Barber J, Sharkis S, Jones R . Inhibition of apoptosis by BCR-ABL in chronic myeloid leukemia. Blood 1994; 83: 2038\u20132044.","journal-title":"Blood"},{"key":"BFleu2012331_CR7","doi-asserted-by":"publisher","first-page":"5887","DOI":"10.1002\/j.1460-2075.1994.tb06934.x","volume":"13","author":"JH Kabarowski","year":"1994","unstructured":"Kabarowski JH, Allen PB, Wiedemann LM . A temperature sensitive p210 BCR-ABL mutant defines the primary consequences of BCR-ABL tyrosine kinase expression in growth factor dependent cells. EMBO J 1994; 13: 5887\u20135895.","journal-title":"EMBO J"},{"key":"BFleu2012331_CR8","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1172\/JCI115985","volume":"90","author":"CM Verfaillie","year":"1992","unstructured":"Verfaillie CM, McCarthy JB, McGlave PB . Mechanisms underlying abnormal trafficking of malignant progenitors in chronic myelogenous leukemia. Decreased adhesion to stroma and fibronectin but increased adhesion to the basement membrane components laminin and collagen type IV. J Clin Invest 1992; 90: 1232\u20131241.","journal-title":"J Clin Invest"},{"key":"BFleu2012331_CR9","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1038\/328342a0","volume":"328","author":"MY Gordon","year":"1987","unstructured":"Gordon MY, Dowding CR, Riley GP, Goldman JM, Greaves MF . Altered adhesive interactions with marrow stroma of haematopoietic progenitor cells in chronic myeloid leukaemia. Nature 1987; 328: 342\u2013344.","journal-title":"Nature"},{"key":"BFleu2012331_CR10","doi-asserted-by":"publisher","first-page":"2406","DOI":"10.1182\/blood.V97.8.2406","volume":"97","author":"RC Zhao","year":"2001","unstructured":"Zhao RC, Jiang Y, Verfaillie CM . A model of human p210(bcr\/ABL)-mediated chronic myelogenous leukemia by transduction of primary normal human CD34(+) cells with a BCR\/ABL-containing retroviral vector. Blood 2001; 97: 2406\u20132412.","journal-title":"Blood"},{"key":"BFleu2012331_CR11","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1634\/stemcells.20-3-259","volume":"20","author":"A Peled","year":"2002","unstructured":"Peled A, Hardan I, Trakhtenbrot L, Gur E, Magid M, Darash-Yahana M et al. Immature leukemic CD34+CXCR4+ cells from CML patients have lower integrin-dependent migration and adhesion in response to the chemokine SDF-1. Stem Cells 2002; 20: 259\u2013266.","journal-title":"Stem Cells"},{"key":"BFleu2012331_CR12","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1126\/science.2406902","volume":"247","author":"GQ Daley","year":"1990","unstructured":"Daley GQ, Van Etten RA, Baltimore D . Induction of chronic myelogenous leukemia in mice by the P210bcr\/abl gene of the Philadelphia chromosome. Science 1990; 247: 824\u2013830.","journal-title":"Science"},{"key":"BFleu2012331_CR13","doi-asserted-by":"publisher","first-page":"6649","DOI":"10.1073\/pnas.87.17.6649","volume":"87","author":"MA Kelliher","year":"1990","unstructured":"Kelliher MA, McLaughlin J, Witte ON, Rosenberg N . Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR\/ABL. Proc Natl Acad Sci USA 1990; 87: 6649\u20136653.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR14","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1016\/0092-8674(84)90438-0","volume":"37","author":"JB Konopka","year":"1984","unstructured":"Konopka JB, Watanabe SM, Witte ON . An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity. Cell 1984; 37: 1035\u20131042.","journal-title":"Cell"},{"key":"BFleu2012331_CR15","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1182\/blood.V86.10.3897.bloodjournal86103897","volume":"86","author":"RL Ilaria","year":"1995","unstructured":"Ilaria RL, Van Etten RA . The SH2 domain of P210BCR\/ABL is not required for the transformation of hematopoietic factor-dependent cells. Blood 1995; 86: 3897\u20133904.","journal-title":"Blood"},{"key":"BFleu2012331_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/S0092-8674(05)80094-7","volume":"75","author":"AM Pendergast","year":"1993","unstructured":"Pendergast AM, Quilliam LA, Cripe LD, Bassing CH, Dai Z, Li N et al. BCR-ABL-induced oncogenesis is mediated by direct interaction with the SH2 domain of the GRB-2 adaptor protein. Cell 1993; 75: 175\u2013185.","journal-title":"Cell"},{"key":"BFleu2012331_CR17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V86.2.726.bloodjournal862726","volume":"86","author":"T Skorski","year":"1995","unstructured":"Skorski T, Kanakaraj P, Nieborowska-Skorska M, Ratajczak MZ, Wen SC, Zon G et al. Phosphatidylinositol-3 kinase activity is regulated by BCR\/ABL and is required for the growth of Philadelphia chromosome-positive cells. Blood 1995; 86: 726\u2013736.","journal-title":"Blood"},{"key":"BFleu2012331_CR18","doi-asserted-by":"publisher","first-page":"31704","DOI":"10.1074\/jbc.271.49.31704","volume":"271","author":"RL Ilaria","year":"1996","unstructured":"Ilaria RL, Van Etten RA . P210 and P190(BCR\/ABL) induce the tyrosine phosphorylation and DNA binding activity of multiple specific STAT family members. J Biol Chem 1996; 271: 31704\u201331710.","journal-title":"J Biol Chem"},{"key":"BFleu2012331_CR19","first-page":"247","volume":"13","author":"K Shuai","year":"1996","unstructured":"Shuai K, Halpern J, ten Hoeve J, Rao X, Sawyers CL . Constitutive activation of STAT5 by the BCR-ABL oncogene in chronic myelogenous leukemia. Oncogene 1996; 13: 247\u2013254.","journal-title":"Oncogene"},{"key":"BFleu2012331_CR20","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1084\/jem.183.3.811","volume":"183","author":"N Carlesso","year":"1996","unstructured":"Carlesso N, Frank DA, Griffin JD . Tyrosyl phosphorylation and DNA binding activity of signal transducers and activators of transcription (STAT) proteins in hematopoietic cell lines transformed by Bcr\/Abl. J Exp Med 1996; 183: 811\u2013820.","journal-title":"J Exp Med"},{"key":"BFleu2012331_CR21","first-page":"1724","volume":"10","author":"DA Frank","year":"1996","unstructured":"Frank DA, Varticovski L . BCR\/abl leads to the constitutive activation of Stat proteins, and shares an epitope with tyrosine phosphorylated Stats. Leukemia 1996; 10: 1724\u20131730.","journal-title":"Leukemia"},{"key":"BFleu2012331_CR22","doi-asserted-by":"publisher","first-page":"11746","DOI":"10.1073\/pnas.92.25.11746","volume":"92","author":"AB Raitano","year":"1995","unstructured":"Raitano AB, Halpern JR, Hambuch TM, Sawyers CL . The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation. Proc Natl Acad Sci USA 1995; 92: 11746\u201311750.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR23","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1038\/sj.leu.2401231","volume":"12","author":"S Mahlmann","year":"1998","unstructured":"Mahlmann S, McLaughlin J, Afar DE, Mohr R, Kay RJ, Witte ON . Dissection of signaling pathways and cloning of new signal transducers in tyrosine kinase-induced pathways by genetic selection. Leukemia 1998; 12: 1858\u20131865.","journal-title":"Leukemia"},{"key":"BFleu2012331_CR24","doi-asserted-by":"publisher","first-page":"11858","DOI":"10.1073\/pnas.95.20.11858","volume":"95","author":"T Skorski","year":"1998","unstructured":"Skorski T, Wlodarski P, Daheron L, Salomoni P, Nieborowska-Skorska M, Majewski M et al. BCR\/ABL-mediated leukemogenesis requires the activity of the small GTP-binding protein Rac. Proc Natl Acad Sci USA 1998; 95: 11858\u201311862.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR25","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","volume":"13","author":"L Puil","year":"1994","unstructured":"Puil L, Liu J, Gish G, Mbamalu G, Bowtell D, Pelicci PG et al. Bcr-Abl oncoproteins bind directly to activators of the Ras signalling pathway. EMBO J 1994; 13: 764\u2013773.","journal-title":"EMBO J"},{"key":"BFleu2012331_CR26","first-page":"839","volume":"12","author":"M Sattler","year":"1996","unstructured":"Sattler M, Salgia R, Okuda K, Uemura N, Durstin MA, Pisick E et al. The proto-oncogene product p120CBL and the adaptor proteins CRKL and c-CRK link c-ABL, p190BCR\/ABL and p210BCR\/ABL to the phosphatidylinositol-3' kinase pathway. Oncogene 1996; 12: 839\u2013846.","journal-title":"Oncogene"},{"key":"BFleu2012331_CR27","first-page":"1385","volume":"10","author":"D Harrison-Findik","year":"1995","unstructured":"Harrison-Findik D, Susa M, Varticovski L . Association of phosphatidylinositol 3-kinase with SHC in chronic myelogeneous leukemia cells. Oncogene 1995; 10: 1385\u20131391.","journal-title":"Oncogene"},{"key":"BFleu2012331_CR28","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1182\/blood.V88.5.1542.1542","volume":"88","author":"SK Jain","year":"1996","unstructured":"Jain SK, Susa M, Keeler ML, Carlesso N, Druker B, Varticovski L . PI 3-kinase activation in BCR\/abl-transformed hematopoietic cells does not require interaction of p85 SH2 domains with p210 BCR\/abl. Blood 1996; 88: 1542\u20131550.","journal-title":"Blood"},{"key":"BFleu2012331_CR29","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1182\/blood.V84.6.1731.1731","volume":"84","author":"J ten Hoeve","year":"1994","unstructured":"ten Hoeve J, Arlinghaus RB, Guo JQ, Heisterkamp N, Groffen J . Tyrosine phosphorylation of CRKL in Philadelphia+ leukemia. Blood 1994; 84: 1731\u20131736.","journal-title":"Blood"},{"key":"BFleu2012331_CR30","doi-asserted-by":"publisher","first-page":"21468","DOI":"10.1074\/jbc.270.37.21468","volume":"270","author":"R de Jong","year":"1995","unstructured":"de Jong R, ten Hoeve J, Heisterkamp N, Groffen J . Crkl is complexed with tyrosine-phosphorylated Cbl in Ph-positive leukemia. J Biol Chem 1995; 270: 21468\u201321471.","journal-title":"J Biol Chem"},{"key":"BFleu2012331_CR31","doi-asserted-by":"publisher","first-page":"16170","DOI":"10.1074\/jbc.272.26.16170","volume":"272","author":"A Bhat","year":"1997","unstructured":"Bhat A, Kolibaba K, Oda T, Ohno-Jones S, Heaney C, Druker BJ . Interactions of CBL with BCR-ABL and CRKL in BCR-ABL-transformed myeloid cells. J Biol Chem 1997; 272: 16170\u201316175.","journal-title":"J Biol Chem"},{"key":"BFleu2012331_CR32","doi-asserted-by":"publisher","first-page":"4515","DOI":"10.1002\/j.1460-2075.1994.tb06773.x","volume":"13","author":"C Andoniou","year":"1994","unstructured":"Andoniou C, Thien C, Langdon W . Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene. EMBO J 1994; 13: 4515\u20134523.","journal-title":"EMBO J"},{"key":"BFleu2012331_CR33","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1073\/pnas.86.4.1168","volume":"86","author":"WY Langdon","year":"1989","unstructured":"Langdon WY, Hartley JW, Klinken SP, Ruscetti SK, Morse HC . v-cbl, an oncogene from a dual-recombinant murine retrovirus that induces early B-lineage lymphomas. Proc Natl Acad Sci USA 1989; 86: 1168\u20131172.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR34","doi-asserted-by":"publisher","first-page":"15547","DOI":"10.1073\/pnas.95.26.15547","volume":"95","author":"M Naramura","year":"1998","unstructured":"Naramura M, Kole HK, Hu RJ, Gu H . Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc Natl Acad Sci USA 1998; 95: 15547\u201315552.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR35","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.1128\/MCB.18.8.4872","volume":"18","author":"MA Murphy","year":"1998","unstructured":"Murphy MA, Schnall RG, Venter DJ, Barnett L, Bertoncello I, Thien CB et al. Tissue hyperplasia and enhanced T-cell signalling via ZAP-70 in c-Cbl-deficient mice. Mol Cell Biol 1998; 18: 4872\u20134882.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012331_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/35003228","volume":"403","author":"K Bachmaier","year":"2000","unstructured":"Bachmaier K, Krawczyk C, Kozieradzki I, Kong Y, Sasaki T, Oliveira-dos-Santos A et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 2000; 403: 211\u2013216.","journal-title":"Nature"},{"key":"BFleu2012331_CR37","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/35003235","volume":"403","author":"YJ Chiang","year":"2000","unstructured":"Chiang YJ, Kole HK, Brown K, Naramura M, Fukuhara S, Hu RJ et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 2000; 403: 216\u2013220.","journal-title":"Nature"},{"key":"BFleu2012331_CR38","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1038\/nrm1762","volume":"6","author":"MH Schmidt","year":"2005","unstructured":"Schmidt MH, Dikic I . The Cbl interactome and its functions. Nat Rev Mol Cell Biol 2005; 6: 907\u2013918.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"BFleu2012331_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bcmd.2005.12.035","volume":"36","author":"S Okabe","year":"2006","unstructured":"Okabe S, Tauchi T, Ohyashiki K, Broxmeyer HE . Stromal-cell-derived factor-1\/CXCL12-induced chemotaxis of a T cell line involves intracellular signaling through Cbl and Cbl-b and their regulation by Src kinases and CD45. Blood Cells Mol Dis 2006; 36: 308\u2013314.","journal-title":"Blood Cells Mol Dis"},{"key":"BFleu2012331_CR40","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1182\/blood.V97.3.608","volume":"97","author":"RD Chernock","year":"2001","unstructured":"Chernock RD, Cherla RP, Ganju RK . SHP2 and cbl participate in alpha-chemokine receptor CXCR4-mediated signaling pathways. Blood 2001; 97: 608\u2013615.","journal-title":"Blood"},{"key":"BFleu2012331_CR41","doi-asserted-by":"publisher","first-page":"8852","DOI":"10.1038\/sj.onc.1206892","volume":"22","author":"DM Dinulescu","year":"2003","unstructured":"Dinulescu DM, Wood LJ, Shen L, Loriaux M, Corless CL, Gross AW et al. c-CBL is not required for leukemia induction by Bcr-Abl in mice. Oncogene 2003; 22: 8852\u20138860.","journal-title":"Oncogene"},{"key":"BFleu2012331_CR42","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1038\/sj.onc.1201430","volume":"15","author":"XR Bustelo","year":"1997","unstructured":"Bustelo XR, Crespo P, Lopez-Barahona M, Gutkind JS, Barbacid M . Cbl-b, a member of the Sli-1\/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene 1997; 15: 2511\u20132520.","journal-title":"Oncogene"},{"key":"BFleu2012331_CR43","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1038\/sj.onc.1205202","volume":"21","author":"M Sattler","year":"2002","unstructured":"Sattler M, Pride YB, Quinnan LR, Verma S, Malouf NA, Husson H et al. Differential expression and signaling of CBL and CBL-B in BCR\/ABL transformed cells. Oncogene 2002; 21: 1423\u20131433.","journal-title":"Oncogene"},{"key":"BFleu2012331_CR44","doi-asserted-by":"publisher","first-page":"32704","DOI":"10.1074\/jbc.M103100200","volume":"276","author":"MH Nguyen","year":"2001","unstructured":"Nguyen MH, Ho JM, Beattie BK, Barber DL . TEL-JAK2 mediates constitutive activation of the phosphatidylinositol 3'-kinase\/protein kinase B signaling pathway. J Biol Chem 2001; 276: 32704\u201332713.","journal-title":"J Biol Chem"},{"key":"BFleu2012331_CR45","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/blood.V92.10.3780","volume":"92","author":"WS Pear","year":"1998","unstructured":"Pear WS, Miller JP, Xu L, Pui JC, Soffer B, Quackenbush RC et al. Efficient and rapid induction of a chronic myelogenous leukemia-like myeloproliferative disease in mice receiving P210 bcr\/abl-transduced bone marrow. Blood 1998; 92: 3780\u20133792.","journal-title":"Blood"},{"key":"BFleu2012331_CR46","first-page":"1438","volume":"100","author":"JM Ho","year":"2002","unstructured":"Ho JM, Nguyen MH, Dierov JK, Badger KM, Beattie BK, Tartaro P et al. TEL-JAK2 constitutively activates the extracellular signal-regulated kinase (ERK), stress-activated protein\/Jun kinase (SAPK\/JNK), and p38 signaling pathways. Blood 2002; 100: 1438\u20131448.","journal-title":"Blood"},{"key":"BFleu2012331_CR47","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1084\/jem.189.9.1399","volume":"189","author":"S Li","year":"1999","unstructured":"Li S, Ilaria RL, Million RP, Daley GQ, Van Etten RA . The P190, P210, and P230 forms of the BCR\/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity. J Exp Med 1999; 189: 1399\u20131412.","journal-title":"J Exp Med"},{"key":"BFleu2012331_CR48","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/nm886","volume":"9","author":"F Mazurier","year":"2003","unstructured":"Mazurier F, Doedens M, Gan O, Dick J . Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells. Nat Med 2003; 9: 959\u2013963.","journal-title":"Nat Med"},{"key":"BFleu2012331_CR49","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/blood.V92.10.3829.422k14_3829_3840","volume":"92","author":"X Zhang","year":"1998","unstructured":"Zhang X, Ren R . Bcr-Abl efficiently induces a myeloproliferative disease and production of excess interleukin-3 and granulocyte-macrophage colony-stimulating factor in mice: a novel model for chronic myelogenous leukemia. Blood 1998; 92: 3829\u20133840.","journal-title":"Blood"},{"key":"BFleu2012331_CR50","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1182\/blood-2003-09-3033","volume":"104","author":"SD Pelletier","year":"2004","unstructured":"Pelletier SD, Hong DS, Hu Y, Liu Y, Li S . Lack of the adhesion molecules P-selectin and intercellular adhesion molecule-1 accelerate the development of BCR\/ABL-induced chronic myeloid leukemia-like myeloproliferative disease in mice. Blood 2004; 104: 2163\u20132171.","journal-title":"Blood"},{"key":"BFleu2012331_CR51","doi-asserted-by":"publisher","first-page":"6082","DOI":"10.1128\/MCB.02202-05","volume":"26","author":"IJ Griswold","year":"2006","unstructured":"Griswold IJ, MacPartlin M, Bumm T, Goss VL, O'Hare T, Lee KA et al. Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib. Mol Cell Biol 2006; 26: 6082\u20136093.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012331_CR52","doi-asserted-by":"publisher","first-page":"12804","DOI":"10.1073\/pnas.96.22.12804","volume":"96","author":"X Jiang","year":"1999","unstructured":"Jiang X, Lopez A, Holyoake T, Eaves A, Eaves C . Autocrine production and action of IL-3 and granulocyte colony-stimulating factor in chronic myeloid leukemia. Proc Natl Acad Sci USA 1999; 96: 12804\u201312809.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR53","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1182\/blood.V97.5.1442","volume":"97","author":"S Li","year":"2001","unstructured":"Li S, Gillessen S, Tomasson MH, Dranoff G, Gilliland DG, Van Etten RA . Interleukin 3 and granulocyte-macrophage colony-stimulating factor are not required for induction of chronic myeloid leukemia-like myeloproliferative disease in mice by BCR\/ABL. Blood 2001; 97: 1442\u20131450.","journal-title":"Blood"},{"key":"BFleu2012331_CR54","doi-asserted-by":"publisher","first-page":"11630","DOI":"10.1073\/pnas.2035020100","volume":"100","author":"S Wong","year":"2003","unstructured":"Wong S, McLaughlin J, Cheng D, Shannon K, Robb L, Witte ON . IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease. Proc Natl Acad Sci USA 2003; 100: 11630\u201311635.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR55","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1182\/blood-2006-12-061176","volume":"110","author":"MA Caligiuri","year":"2007","unstructured":"Caligiuri MA, Briesewitz R, Yu J, Wang L, Wei M, Arnoczky KJ et al. Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemia. Blood 2007; 110: 1022\u20131024.","journal-title":"Blood"},{"key":"BFleu2012331_CR56","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1182\/blood-2007-01-066076","volume":"110","author":"B Sargin","year":"2007","unstructured":"Sargin B, Choudhary C, Crosetto N, Schmidt MH, Grundler R, Rensinghoff M et al. Flt3-dependent transformation by inactivating c-Cbl mutations in AML. Blood 2007; 110: 1004\u20131012.","journal-title":"Blood"},{"key":"BFleu2012331_CR57","doi-asserted-by":"publisher","first-page":"10349","DOI":"10.1158\/0008-5472.CAN-08-2754","volume":"68","author":"AJ Dunbar","year":"2008","unstructured":"Dunbar AJ, Gondek LP, O'Keefe CL, Makishima H, Rataul MS, Szpurka H et al. 250K single nucleotide polymorphism array karyotyping identifies acquired uniparental disomy and homozygous mutations, including novel missense substitutions of c-Cbl, in myeloid malignancies. Cancer Res 2008; 68: 10349\u201310357.","journal-title":"Cancer Res"},{"key":"BFleu2012331_CR58","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ccr.2010.09.008","volume":"18","author":"C Rathinam","year":"2010","unstructured":"Rathinam C, Thien CB, Flavell RA, Langdon WY . Myeloid leukemia development in c-Cbl RING finger mutant mice is dependent on FLT3 signaling. Cancer Cell 2010; 18: 341\u2013352.","journal-title":"Cancer Cell"},{"key":"BFleu2012331_CR59","doi-asserted-by":"publisher","first-page":"16274","DOI":"10.1073\/pnas.1007575107","volume":"107","author":"M Naramura","year":"2010","unstructured":"Naramura M, Nandwani N, Gu H, Band V, Band H . Rapidly fatal myeloproliferative disorders in mice with deletion of Casitas B-cell lymphoma (Cbl) and Cbl-b in hematopoietic stem cells. Proc Natl Acad Sci USA 2010; 107: 16274\u201316279.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFleu2012331_CR60","doi-asserted-by":"publisher","first-page":"2957","DOI":"10.1182\/blood.V99.8.2957","volume":"99","author":"Y He","year":"2002","unstructured":"He Y, Wertheim JA, Xu L, Miller JP, Karnell FG, Choi JK et al. The coiled-coil domain and Tyr177 of bcr are required to induce a murine chronic myelogenous leukemia-like disease by bcr\/abl. Blood 2002; 99: 2957\u20132968.","journal-title":"Blood"},{"key":"BFleu2012331_CR61","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1182\/blood.V96.2.664","volume":"96","author":"RP Million","year":"2000","unstructured":"Million RP, Van Etten RA . The Grb2 binding site is required for the induction of chronic myeloid leukemia-like disease in mice by the Bcr\/Abl tyrosine kinase. Blood 2000; 96: 664\u2013670.","journal-title":"Blood"},{"key":"BFleu2012331_CR62","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1128\/MCB.21.3.840-853.2001","volume":"21","author":"X Zhang","year":"2001","unstructured":"Zhang X, Subrahmanyam R, Wong R, Gross AW, Ren R . The NH(2)-terminal coiled-coil domain and tyrosine 177 play important roles in induction of a myeloproliferative disease in mice by Bcr-Abl. Mol Cell Biol 2001; 21: 840\u2013853.","journal-title":"Mol Cell Biol"},{"key":"BFleu2012331_CR63","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1182\/blood.V91.2.406","volume":"91","author":"T Skorski","year":"1998","unstructured":"Skorski T, Nieborowska-Skorska M, Wlodarski P, Wasik M, Trotta R, Kanakaraj P et al. The SH3 domain contributes to BCR\/ABL-dependent leukemogenesis in vivo: role in adhesion, invasion, and homing. Blood 1998; 91: 406\u2013418.","journal-title":"Blood"},{"key":"BFleu2012331_CR64","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/ni0901-870","volume":"2","author":"D Fang","year":"2001","unstructured":"Fang D, Liu YC . Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nat Immunol 2001; 2: 870\u2013875.","journal-title":"Nat Immunol"},{"key":"BFleu2012331_CR65","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/nm1489","volume":"12","author":"DS Krause","year":"2006","unstructured":"Krause DS, Lazarides K, von Andrian UH, Van Etten RA . Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells. Nat Med 2006; 12: 1175\u20131180.","journal-title":"Nat Med"},{"key":"BFleu2012331_CR66","doi-asserted-by":"publisher","first-page":"3607","DOI":"10.1182\/blood-2007-07-103077","volume":"111","author":"EY Choi","year":"2008","unstructured":"Choi EY, Orlova VV, Fagerholm SC, Nurmi SM, Zhang L, Ballantyne CM et al. Regulation of LFA-1-dependent inflammatory cell recruitment by Cbl-b and 14-3-3 proteins. Blood 2008; 111: 3607\u20133614.","journal-title":"Blood"},{"key":"BFleu2012331_CR67","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1034\/j.1600-065X.2000.00601.x","volume":"176","author":"MR Gold","year":"2000","unstructured":"Gold MR, Ingham RJ, McLeod SJ, Christian SL, Scheid MP, Duronio V et al. Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase\/Akt\/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol Rev 2000; 176: 47\u201368.","journal-title":"Immunol Rev"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu2012331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012331","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu2012331.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T15:39:01Z","timestamp":1648741141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2012331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,19]]},"references-count":67,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFleu2012331"],"URL":"https:\/\/doi.org\/10.1038\/leu.2012.331","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,19]]},"assertion":[{"value":"31 August 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2012","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2012","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2012","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}